SCHEMBL25820730

SCHEMBL25820730

N#Cc1ccc2nccc(Nc3cccc(NC(=O)c4cccc(Nc5ccccc5)c4)c3)c2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 7/20 0.64
DNMT3A Q9Y6K1 6/20 0.64
BRAF P15056 3/20 0.54
DNMT3L Q9UJW3 4/20 0.54
EHMT1 Q9H9B1 2/20 0.54
GAK O14976 1/20 0.48
RIPK2 O43353 1/20 0.48
COQ8A Q8NI60 1/20 0.48
NLK Q9UBE8 1/20 0.48
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
F2 P00734 1/20 0.47
PLG P00747 1/20 0.47
PLAU P00749 1/20 0.47
KLKB1 P03952 1/20 0.47
PRSS1 P07477 1/20 0.47
MAPKAPK2 P49137 2/20 0.46
GRM4 Q14833 1/20 0.46
ABL1 P00519 1/20 0.46
PDGFRB P09619 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24010972 1.00 DNMT1 (0.64) DNMT1DNMT3ABRAFDNMT3LEHMT1
SCHEMBL24006169 0.96 DNMT1 (0.70) DNMT1DNMT3ABRAFDNMT3LEHMT1
SCHEMBL19151331 0.94 DNMT1 (0.59) DNMT1DNMT3ABRAFDNMT3LEHMT1
SCHEMBL25487871 0.94 DNMT1 (0.59) DNMT1DNMT3ABRAFDNMT3LEHMT1
SCHEMBL30290822 0.94 DNMT1 (0.59) DNMT1DNMT3ABRAFDNMT3LEHMT1
SCHEMBL24003789 0.94 DNMT1 (0.59) DNMT1DNMT3ABRAFDNMT3LEHMT1
SCHEMBL25820597 0.94 DNMT1 (0.59) DNMT1DNMT3ABRAFDNMT3LEHMT1
SCHEMBL25820628 0.93 DNMT1 (0.58) DNMT1DNMT3ABRAFDNMT3LEHMT1
SCHEMBL25820611 0.93 DNMT1 (0.58) DNMT1DNMT3ABRAFDNMT3LEHMT1
SCHEMBL25820569 0.93 DNMT1 (0.60) DNMT1DNMT3ABRAFDNMT3LEHMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885BRAF 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.